Institute for Brain Health Research
The Equity Medical Institute for Brain Health Research in Memphis, TN, combines specialized investigator expertise with Equity Medical’s clinical research infrastructure to support complex neurology, psychiatry, sleep, and ophthalmology trials.
Led by Joshua Lennon, MD, a board-certified neurologist and sleep medicine specialist, and Michael Wertheimer, MD, a board-certified ophthalmologist, the institute is equipped for trials spanning neurodegenerative disease, neurological conditions, ophthalmological diseases, and sleep and wake disorders.
Brain Health Research Expertise
Our investigators and research team support clinical trials across four areas of brain, nerve, eye, and sleep health:
Joshua Lennon, MD
Board-Certified Neurologist & Sleep Medicine Specialist
Dr. Joshua Lennon brings extensive Phase I–IV CNS trial experience across neurodegenerative and sleep disorders. He is dual board-certified in Neurology and Sleep Medicine and board-eligible in Obesity Medicine.
His clinical trial experience includes disease-modifying Alzheimer’s therapies, neuropsychiatric assessments, and Data Safety Monitoring Boards.
Michael Wertheimer, MD
Board-Certified Ophthalmologist
Dr. Michael Wertheimer brings over 15 years of ophthalmology experience and Phase II–III clinical trial expertise.
His research spans geographic atrophy, diabetic retinal diseases, and wet age-related macular degeneration, with experience in investigational gene therapies and intravitreal treatments.
Mobile Research Capabilities
Our mobile clinical research units extend the Equity Medical Institute for Brain Health Research beyond the traditional site, bringing research closer to the Memphis community.
The mobile units support select trial activities, community health screenings, and outreach across the Memphis region, including:
